6 days Ago By ABMN Staff
Mariner LLC lifted its holdings in shares of ICU Medical, Inc. ( NASDAQ:ICUI – Free Report ) by 24.4% in the 4th quarter, according to its most recent Form 13F filing with the SEC.
The firm owned 5,009 shares of the medical instruments supplier’s stock after buying an additional 984 shares during the period. Mariner LLC’s holdings in ICU Medical were worth $777,000 at the end of the most recent quarter. Several other hedge funds have also made changes to their positions in ICUI.
Harvest Fund Management Co. Ltd purchased a new position in ICU Medical during the fourth quarter worth about $33,000. Murphy & Mullick Capital Management Corp purchased a new position in ICU Medical during the fourth quarter worth about $52,000.
Venturi Wealth Management LLC raised its holdings in ICU Medical by 64.0% during the fourth quarter. Venturi Wealth Management LLC now owns 528 shares of the medical instruments supplier’s stock worth $82,000 after purchasing an additional 206 shares in the last quarter.
Russell Investments Group Ltd. raised its holdings in ICU Medical by 88.8% during the fourth quarter.
Russell Investments Group Ltd. now owns 638 shares of the medical instruments supplier’s stock worth $99,000 after purchasing an additional 300 shares in the last quarter. Finally, Sterling Capital Management LLC raised its holdings in ICU Medical by 813.
5% during the fourth quarter. Sterling Capital Management LLC now owns 676 shares of the medical instruments supplier’s stock worth $105,000 after purchasing an additional 602 shares in the last quarter. Institutional investors and hedge funds own 96.
10% of the company’s stock. Wall Street Analysts Forecast Growth ICUI has been the subject of several analyst reports. KeyCorp cut their price target on shares of ICU Medical from $209.
00 to $191.00 and set an “overweight” rating for the company in a report on Monday, April 21st. StockNews.
com cut shares of ICU Medical from a “buy” rating to a “hold” rating in a report on Thursday, April 24th. Raymond James set a $97.00 target price on shares of ICU Medical in a report on Wednesday, March 12th.
Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of ICU Medical in a report on Tuesday, April 8th. Two investment analysts have rated the stock with a hold rating, two have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $162.
67. ICU Medical Trading Up 0.2 % Shares of ICU Medical stock opened at $135.
90 on Tuesday. The company has a 50-day moving average of $143.25 and a two-hundred day moving average of $157.
64. The stock has a market cap of $3.34 billion, a PE ratio of -29.
74 and a beta of 0.86. ICU Medical, Inc.
has a 12-month low of $95.44 and a 12-month high of $196.26.
The company has a current ratio of 2.29, a quick ratio of 1.03 and a debt-to-equity ratio of 0.
75. ICU Medical Profile ( Free Report ) ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.
Read More Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter ..
